Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	40.25M
Revenue (ttm)	82.88M
Net Income (ttm)	3.68M
Shares Out	35.00M
EPS (ttm)	0.11
PE Ratio	10.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,872
Average Volume	14,496
Open	1.140
Previous Close	1.150
Day's Range	1.130 - 1.150
52-Week Range	1.120 - 1.360
Beta	0.26
RSI	34.00
Earnings Date	Jul 31, 2025

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,111
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.